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© 2010 The Japan Society of Histochemistry and Cy- Alopecia areata (AAR) and androgenetic alopecia (AGA) are two major forms of alopecia
based on altered hair growth condition. In general, the cell cycle is regulated by several
mechanisms including the stem cell factor/c-kit signaling. To assess a role for stem cell ac-
tivity in alopecia, we performed histopathological, immunohistochemical, and semiquantita-
tive analyses of c-kit as well as Ki-67 in scalp biopsy specimens obtained from 14 patients
with AAR, 18 patients with AGA, and 6 age-matched control subjects, using the specific
antibodies. Formalin-fixed, paraffin-embedded skin sections were examined. Immunoreactiv-
ities for Ki-67 and c-kit were localized in keratinocytes and melanocytes in the outermost lay-
er of hair follicles. The mean length of hair follicles was significantly shorter in the AAR and
AGA groups than in the control group. The mean number of Ki-67-immunoreactive cells per
follicle was significantly reduced in the AAR and AGA groups as compared with the control
group. The mean number of c-kit-immunoreactive cells per follicle was significantly in-
creased in the AAR and AGA groups as compared with the control group. Our results indi-
cate that c-kit is upregulated in the hair follicle cells in these forms of alopecia, and suggest
that the upregulation reflects a negative feedback mechanism in response to possible down-
regulation of the ligand stem cell factor.
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I. Introduction
Hair has a great social significance for human beings.
Human hair growth activity reflects both physiological and
pathological conditions. Normal hair is seen in healthy,
young individuals, while baldness and white hair increase
in an age-dependent manner [2, 32]. Alopecia areata (AAR)
and androgenetic alopecia (AGA) are two major common
forms of alopecia that affect young and old people alike [2].
In AAR, the skin lesions are characterized by bald spots, and
they usually appear on the scalp and show a local or exten-
sive distribution [2, 23]. In 1–2% of the AAR cases, skin le-
sions involve the entire scalp (alopecia totalis) or the entire
epidermis of the body skin (alopecia universalis) [23]. A
growing body of evidence implicates several mechanisms
mediated by neuropeptide stimuli, autoimmunity, heredity,
stress, and so on in the pathomechanism of AAR [2, 5, 14].
In AGA, skin lesions are characterized by well defined loss
of hair that usually involves the marginal zone adjacent to
the face and spreads into the bilateral upper sides known as
male pattern baldness [2, 11, 23]. Given that male hormones
including androgens act as a main regulator of hair growth,
the involvement of hormonal imbalance and altered sensitiv-Ashrafuzzaman et al. 10
ity to androgen in the hair follicle has been discussed; exces-
sive production of androgen and reduced production of
estrogen inhibit hair growth [11, 23], and overexpression
or variation of the androgen receptor gene promotes male
pattern baldness [9, 23].
Recent studies have identified stem cells in various or-
gans and tissues including the epithelium of the hair follicle,
skin (epidermis), and intestinal mucosa, as well as the cen-
tral nervous system and bone marrow [10, 12, 19]. Tissue
stem cells are the body’s master cells with the ability to
differentiate into tissue-specific precursor and specialized
cells; the former cells actually proliferate, create tissue bulk,
and play a critical role in maintenance of tissue structures
and homeostasis [10, 19]. Mounting evidence suggests that
altered activities of tissue stem cells have relevance to cer-
tain pathological conditions such as tumorigenesis [16] and
degenerative disorders [13]. It is known that stromal cells
produce and release the growth factor stem cell factor (SCF),
which stimulates cells expressing the SCF receptor c-kit [3,
6, 7, 17, 31], also called CD117. This receptor is a trans-
membrane protein [1] that is localized on the cell surface of
hematopoietic stem cells and other cell types and acts as a
receptor for SCF [3, 6, 7, 17, 31]. The binding of SCF to
c-kit transactivates the receptor tyrosine kinase to activate
stem cells, and the SCF/c-kit signaling induces cell survival,
differentiation, and proliferation; the latter is evidenced by
the cell proliferation marker Ki-67 [8, 18, 30]. In the hair
follicle, the cells of the keratinocytic and melanocytic lin-
eage are responsible for hair growth and color, respectively,
and express c-kit [4, 25, 26, 29], while stromal cells in the
dermis produce SCF [4, 28]. Thus, it is conjectured that the
SCF/c-kit signaling is involved in the pathological processes
of AAR and AGA. Although this signaling has been well
characterized mainly in animals [4, 21, 25, 26], the involve-
ment of c-kit in human alopecias has not yet been fully
understood. To address this issue, we performed histopatho-
logical, immunohistochemical, and semiquantitative analy-
ses in scalp biopsy specimens, focusing on c-kit.
II. Materials and Methods
Subjects
This study was carried out on scalp skin biopsy
specimens obtained from 14 AAR patients [age: 19–61
(40.50±12.93) yr; sex: 5 males and 9 females], 18 AGA
patients [age: 21–55 (35.78±9.45) yr; sex: 18 males] and 6
age-matched control subjects with other diseases [age:
21–68 (43.17±18.77) yr; sex: 5 males and 1 female]. There
was no significant difference in age at biopsy between the
control, AAR and AGA groups (P>0.05). The biopsy was
achieved under written informed consent from each subject
in accordance with the Declaration of Helsinki revised on
2000. Associated disorders of the control subjects were
sebaceous cyst (n=1), eccrine spiradenoma (n=1), basal cell
epithelioma (n=1), chronic dermatitis (n=1), schwannoma
(n=1) and nevocellular nevus (n=1), and normal-appearing
regions in these control specimens were examined.
Histopathological and immunohistochemical analyses
Multiple 3-μm-thick sections were cut from formalin
(10%)-fixed, paraffin-embedded scalp materials obtained
from each case, and used for hematoxylin-eosin (H&E)
staining and immunohistochemical staining. The primary
antibodies employed in immunohistochemistry were mouse
monoclonal IgG1 against Ki-67 (Clone MIB-1; diluted
1:100; Dako, Glostrup, Denmark), rabbit polyclonal IgG
against c-kit (Cat. No. A4502; diluted 1:1,000; Dako),
mouse monoclonal IgG1 against pancytokeratin (Clone
AE1/AE3; diluted 1:100; Dako), and mouse monoclonal
IgG1 against melan-A (Clone A103; diluted 1:50; Dako).
The last two antigens were used as markers of keratinocytes
and melanocytes, respectively.
Prior to immunostaining for Ki-67 and melan-A,
antigen unmasking was performed by microwaving in
Tris-buffered  ethylenediaminetetraacetic  acid  (TB-EDTA),
pH 9.0, solution (400 W, 95°C, 40 min). Sections were
deparaffinized, rehydrated, quenched for 10 min at room
temperature with 3% hydrogen peroxide to inhibit endog-
enous peroxidase activity, rinsed in phosphate-buffered
saline, pH 7.6 (PBS), pretreated for 20 min at room tempera-
ture with 3% skim milk/PBS solution to inhibit nonspecific
antibody binding, and subsequently incubated overnight
at 4°C with the primary antibodies. Antibody binding was
visualized  by  the  avidin-biotin-immunoperoxidase  com-
plex (ABC) method; 3,3'-diaminobenzidine tetrahydrochlo-
ride (DAB) was the chromogen, and hematoxylin, the
counterstain. Sections processed with omission of the pri-
mary antibodies or incubated with 3% nonimmune serum
derived from the same animal species as those producing
antibodies served as negative reaction controls.
Immunohistochemical localization of Ki-67 and c-kit
was verified by comparison with H&E-stained consecutive
sections. Additionally, c-kit-immunoreactive cells were
strictly identified by the following double immunostaining
procedures. In brief, sections were incubated with the
anti-c-kit antibody, and immunoreaction was detected by
the polymer-immunocomplex (PIC) method using the En-
vision system (Dako) and DAB as the chromogen. After
taking microphotographs of c-kit-immunoreactive cells,
sections were processed by eluting the antibodies by micro-
waving in citrate buffer, pH 6.0, solution (400 W, 95°C,
10 min) for pancytokeratin and by microwaving in TB-
EDTA, pH 9.0, solution (400 W, 95°C, 40 min) for melan-
A. Sections were then incubated with the antibodies to
pancytokeratin and melan-A, and antibody binding was
detected by the PIC method using the Envision system
(Dako) and NiCl2/DAB as the chromogen. The c-kit-
immunoreactive cells were identified by comparison of the
immunohistochemical localization of these cell markers
with that of c-kit on the initially taken microphotographs.
Immunoblot analysis
To verify the specificity of the anti-c-kit antibody, we
performed an immunoblot analysis using three control skin
samples. Archival, freshly frozen skin materials were ho-Involvement of c-kit in Alopecia 11
mogenized with a 10-fold-volume of radioimmunoprecipita-
tion assay (RIPA) buffer containing the protease inhibitor
cocktail Complete Mini® (Roche Diagnostics, Manheim,
Germany) and centrifuged for 1 hr at 10,000×g to obtain
total protein extracts. Protein concentration in the tissue
samples was determined by the Bradford method. After
boiling for 10 min with an equal volume of Laemmli’s sam-
ple buffer, aliquots (30 μg protein/lane) were separated
by 8% sodium dodecyl sulfate gel electrophoresis and
electroblotted onto a polyvinyliden difluoride membrane.
Blots were rinsed in Tris-buffered saline, pH 7.5 containing
Tween 20 (TBS-T), pretreated for 1 hr at room temperature
with 3% bovine serum albumin, and incubated overnight
at 4°C with the anti-c-kit antibody at a dilution of 1:200 in
Can Get Signal® (ToYoBo, Tokyo, Japan) solution followed
by swine anti-rabbit IgG (Dako) at a dilution of 1:25,000
in the Can Get Signal solution. Antibody binding was
visualized by the chemiluminescence method using ECL-
plus kit (GE Healthcare, Buckinghamshire, UK), according
to the manufacturer’s instruction. Blots from which the
primary antibody was omitted served as negative reaction
controls.
Semiquantitative and statistical analyses
Sections stained with H&E and immunostained for
Ki-67 and c-kit were scanned and imported into a personal
computer. The length of hair follicles (μm) in each case
was measured, and the mean length of the follicles was
calculated. The number of hair follicle epithelial cells
immunoreactive for Ki-67 or c-kit in each case was
counted, and the mean number in a follicle was calculated.
All of the values in the control, AAR and AGA groups
were expressed as mean±standard deviation, and compared
between the three groups by non-repeated measures analysis
of variance (ANOVA) followed by unpaired Student’s t-
test. Statistical significance was defined as P value less
than 0.05.
III. Results
Histopathological observations
H&E-stained sections demonstrated a variety of histo-
pathological changes between the control, AAR and AGA
groups (Figs. 1, 2a, 2d, 2g, 3a, 3d, 3g, 4a, 4d, 4g). In the con-
trol group, many of the hair follicles had normal structures
characteristic of the anagen phase, and both the hair bulb and
the inner and outer root sheaths were clearly identified. In
the alopecia groups, the hair follicles tended to show a
marked shortening of the longitudinal length as compared
with the control group, and these histopathological findings
were prominent in the AGA group (Fig. 1). In the AAR
group, hair follicles in the anagen phase were reduced in
number, while many of the follicles showed dystrophic
changes in the hair shafts. Peribulbular lymphocytic infil-
trates were, in particular, observed around the catagen and
telogen follicles, and perivascular lymphocytic infiltrates
were also seen in the dermis and subcutaneous tissue
(Figs. 2–4). In the AGA group, the hair follicles in the telo-
gen phase were increased in number and predominant to
those in the anagen phase, and displayed miniaturization in
the whole structure and hair shaft with variable perivascular
and perifollicular inflammation (Figs. 2–4).
Immunohistochemical observations
Immunoreaction product was undetectable in negative
reaction control sections without the primary antibodies
(data not shown). Ki-67 immunoreactivity was localized
to the cell nuclei in the outermost layer of the hair follicles
and prominent at the hair bulb, and it was most intense in the
control group and the least intense in the AGA group (Figs.
2b, 2e, 2h, 3b, 3e, 3h, 4b, 4e, 4h). By contrast, c-kit immuno-
reactivity was localized to the cell membrane in the outer-
most layer of the hair follicles and prominent in the upper
half of the hair follicles, and it was least intense in the con-
trol group and the most intense in the AGA group (Figs. 2c,
2f, 2i, 3c, 3f, 3i, 4c, 4f, 4i). The Ki-67-immunoreactive cells
Fig. 1. Semimacroscopic findings of scalp biopy specimens obtained from control (a), alopecia areata (b) and androgenetic alopecia (c) cases.
Hematoxylin-eosin staining. Bar=1 mm (a–c).Ashrafuzzaman et al. 12
showed the characteristic morphology of keratinocytes. On
the other side, c-kit immunoreactivity was colocalized
with pancytokeratin-identified keratinocytes and melan-A-
identified melanocytes (Fig. 5). In the examined cases,
c-kit immunoreactivity was only very weak or not detect-
able at all in the hair bulb, where a large number of melanin
pigments were accumulated.
Specificity of anti-c-kit antibody
Immunoblot analysis was performed using total protein
extracts prepared from skin samples (Fig. 6). Immunoblots
disclosed a single band at a 125 kDa mobility. The immuno-
reactive signals were undetectable on negative reaction
control blots.
Changes in length of hair follicles and population of 
epithelial cells expressing Ki67 and c-kit
The length of hair follicles and population of epithelial
cells immunoreactive for Ki-67 and c-kit were statistically
compared among the control, AAR, and AGA groups. The
mean length of the hair follicles was 3.73±0.21 mm in
the control group, 2.6±0.84 mm in the AAR group, and
2.06±0.46 mm in the AGA group (Fig. 7a). ANOVA dis-
closed a significant difference in the mean hair follicle
length among the three groups, and Student’s t-test revealed
that the length was significantly shorter in the AAR and
AGA groups than in the control group. The mean num-
ber of Ki-67-immunoreactive cells per hair follicle was
90.23±31.91 in the control group, 14.19±8.02 in the AAR
group, and 3.52±3.91 in the AGA group (Fig. 7b). ANOVA
disclosed a significant difference in the mean number of the
Ki-67-immunoreactive cells among the three groups, and
Student’s t-test revealed that the number was significantly
reduced in the AAR and AGA groups as compared with the
control group and also smaller in the AGA group than in the
AAR group. The mean number of c-kit-immunoreactive
cells per hair follicle was 3.11±1.58 in the control group,
8.19±2.84 in the AAR group, and 12.89±2.49 in the AGA
group (Fig. 7c). ANOVA disclosed a significant difference
in the mean number of the c-kit-immunoreactive cells
Fig. 2. Photomicrographs of the upper part of hair follicles in control (a–c), alopecia areata (d–f) and androgenetic alopecia (g–i) cases.
Hematoxylin-eosin staining (a, d, g) and immunohistochemical staining for Ki-67 (b, e, h) and c-kit (c, f, i). Insets indicate high magnification
views of immunoreactive cells in blank squares in the corresponding panels. Bar=200 µm (a–i).Involvement of c-kit in Alopecia 13
among the three groups, and Student’s t-test revealed that
the number was significantly increased in the AAR and
AGA groups as compared with the control group and also in-
creased in the AGA group as compared with the AAR group.
IV. Discussion
The structure of hair consists of the hair bulb and shaft,
which exist in the deep dermis and the superficial layer of
subcutaneous tissue, and the hair shaft grows upward
through the epidermis to protrude outside [15, 20, 22, 24,
29]. The hair follicle can be divided into the following three
parts: (1) the infundibulum, (2) the isthmus as the entrance
of the sebaceous gland to the attachment site of the arrector
pili muscle, and (3) the inferior segment. Hair growth de-
pends on the activity of the highly proliferative hair matrix
cells in the hair bulb of the inferior segment. The hair matrix
cells are supplied by slow-cycling and multipotent stem cells
existing in the bulge near the insertion of the arrector pili
muscle [22, 24, 29]. The hair growth cycle consists of the
anagen, catagen, and telogen phases [15, 20, 27, 29]. The
anagen phase is a growth condition of the hair follicle and
normally lasts for several years. The catagen phase is an in-
voluting or regressive condition that follows the anagen
phase and lasts for two or three weeks. The telogen phase is
a resting condition that lasts for approximately three months.
The hair growth cycle varies in length on different parts of
the body [15, 27], and the mean hair growth rate over the
body is 0.3–0.4 mm/day [20, 27]. Thus, our histopathologi-
cal finding of reduced anagen follicles and increased catagen
and telogen follicles in the AAR and AGA groups suggests
a slowed hair growth cycle in alopecia. This is closely rele-
vant to another fact that the mean length of the hair follicle
length was significantly shorter in alopecia. However, it
should be noted that the longitudinal length depends on the
cell proliferating activity in the inferior portion of the hair
follicle.
Ki-67 is a nuclear protein that is strictly expressed only
in actively proliferating cells and thus undetectable in rest-
ing cells as a result of which this protein has been used as an
Fig. 3. Photomicrographs of the middle part of hair follicles in control (a–c), alopecia areata (d–f) and androgenetic alopecia (g–i) cases.
Hematoxylin-eosin staining (a, d, g) and immunohistochemical staining for Ki-67 (b, e, h) and c-kit (c, f, i). Insets show high magnification
views of immunoreactive cells in blank squares in the corresponding panels. Bar=200 µm (a–i).Ashrafuzzaman et al. 14
Fig. 4. Photomicrographs of the lower part of hair follicles in control (a–c), alopecia areata (d–f) and androgenetic alopecia (g–i) cases.
Hematoxylin-eosin staining (a, d, g) and immunohistochemical staining for Ki-67 (b, e, h) and c-kit (c, f, i). Insets indicate high magnification
views of immunoreactive cells in blank squares in the corresponding panels. Bars=200 µm (a–i).
Fig. 5. Identification of c-kit-immunoreactive
cells in the hair follicles of AGA patients by
double immunolabeling. Panels (a) and (b)
show the same region on a section immuno-
stained with the anti-c-kit antibody (brown)
and double immunostained with the anti-
pancytokeratin antibody (blue), respectively.
Panels (c) and (d) show the same region on a
section immunostained with the anti-c-kit anti-
body (brown) and the anti-melan-A antibody
(blue), respectively. Blank and solid arrows
indicate keratinocytes and melanocytes, respec-
tively. Polymer-immunocomplex method using
3,3-diaminobenzidine tetrahydrochloride (DAB)
(a, c) and NiCl2/DAB (b, d). Bar=20 µm (a–d).Involvement of c-kit in Alopecia 15
immunohistochemical marker of cell proliferating activity
[8, 18, 30]. In the present study, the hair follicles in alopecia
showed a shorter length and a reduced number of Ki-67-
immunoreactive cells. These observations indicate hair
growth suppression and the resultant hair follicle atrophy.
It has been shown that Ki-67-immunoreactive cells are
mainly localized in the hair bulb [18], and that a reduced
number of Ki-67-immunoreactive cells is found in the hair
bulb of AAR patients [33]. Thus, our finding of a reduced
number of the immunoreactive cells may result from regres-
sion of the hair follicles. Based on evidence for the mechan-
isms by which male hormones regulate the proliferative
activity of hair follicle cells, it has been suggested that the
altered function of male hormones is involved in AGA [9,
11, 23]. The representative male hormone testosterone is
produced in the testes and hematogenously transported into
the dermal hair papilla, where 5α-reductase catalyzes the
conversion of this hormone to 5α-dihydrotestosterone (5α-
DHT), which exerts more powerful effects [11, 27]. These
male hormones reduce cell division activity and suppress
hair growth activity [11, 27]. Thus, it is conceivable that the
increased effects of male hormones in AGA may be
responsible for our finding that the lowest hair growth ac-
tivity, as evidenced by the lack of Ki-67-immunoreactive
cells, was in the AGA group.
In the anagen phase, the hair follicle keratinocyte stem
cells migrate from the bulge and proliferate to participate in
hair bulb formation during hair growth [22, 24, 29]. By con-
trast, in the catagen and telogen phases, the inferior portion
of hair follicles disappears [15, 20, 23, 29]. The slow-
cycling stem cells in the hair follicles can follow the two
independent stem cell migration pathways. In the bulb-
epidermis stem cell pathway, the corresponding cells mig-
rate upward into the epidermis along the basal lamina,
proliferate within the stratum basalis, and differentiate verti-
cally into the keratin-rich cells of the stratum cornium [22].
In the bulb-hair stem cell pathway, the corresponding cells
migrate downward and induce stromal cells located at the
apex of dermal hair papilla [22, 24, 29]. These cells form
the internal root sheath as well as the cortex and medulla
of the hair shaft [22, 24, 29].
Fig. 6. Immunoblots of total protein extracts from skin samples
using the anti-c-kit antibody. Lanes 1, 2 and 3 indicate molecular
weight markers, negative reaction control, and c-kit-immuno-
reactive signals at a 125 kDa mobility, respectively. Chemilumines-
cence method. Abbreviation: Ab, antibody; MW, molecular weight.
Fig. 7. Statistical comparison of the mean length of hair follicles (a)
and mean population of hair follicle epithelial cells immunoreactive
for Ki-67 (b) and c-kit (c) between the control, alopecia areata and
androgenetic alopecia groups. Asterisks indicate two-tailed P val-
ues obtained with unpaired Student’s t-test. *P<0.001, **P<0.01,
***P<0.05.Ashrafuzzaman et al. 16
There is increasing evidence for the presence of SCF
and c-kit in the skin, although stem cells in the bulge do not
express c-kit [29]. Previous studies documented the expres-
sion of c-kit in melanocytic lineage cells [4, 21, 26, 28, 29,
32]. Recent studies demonstrated that c-kit is expressed in
keratinocytic lineage cells, destined for hair growth, and the
hair matrix of the hair follicles [25], while SCF is expressed
in stromal cells of the hair bulb [4, 28]. Thus, c-kit may be
responsible for hair growth as well as hair pigmentation.
Many of these observations are obtained from animal skins
and in keeping with our findings of the presence of c-kit in
the outermost layer of the hair follicles, with an upper part-
predominant manner, as well as the increased population of
c-kit-immunoreactive hair follicle cells in the AAR and
AGA groups as compared with the control group. However,
our finding of the lack of c-kit in the hair matrix is inconsis-
tent with the results from animal studies. This disparity sug-
gests a difference in the expression pattern of c-kit between
humans and animals. On the other side, the present study
also demonstrated reduced activity of cell proliferation ac-
tivity, as evidenced by Ki-67 staining, in hair follicle cells in
the AAR and AGA groups. In relation to these observations,
it is of interest that both the production and release of the c-
kit ligand SCF from stromal cells in dermal hair papilla are
impaired in AGA [28]. Thus, our finding of the upregulation
of c-kit in the hair follicle cells may reflect a protective
mechanism against the potential downregulation of SCF in
stromal cells in dermal hair papilla.
Taken together, we demonstrated not only the presence
of c-kit and Ki-67 in epithelial cells and melanocytes of the
hair follicles in the control and alopecia cases but also the re-
duced population of Ki-67-expressing cells and increased
population of c-kit-expressing cells in the AAR and AGA
groups as compared with the control group. The present re-
sults suggest a negative feedback mechanism of keratinocyte
stem cells in the hair follicles in response to the possible
downregulation of SCF in stromal cells in dermal hair
papilla. However, both the immunohistochemical localiza-
tion and expression levels of SCF in alopecia skin tissue
remain to be determined. Elucidating these and other issues
concerning the crosstalk between SCF and c-kit in the
skin will contribute to a better understanding of the com-
plete pathomechanisms of alopecias and establishment of
new therapeutic strategies.
V. Acknowledgments
The authors wish to thank Dr. Y. Kato (Department of
Pathology, Tokyo Women’s Medical University) for his
valuable suggestions and also express special thanks to S.
Iwasaki, F. Muramatsu, N. Sakayori, H. Takeiri and M.
Karita for their skillful technical assistance.
VI. References
1. André, C., Martin, E., Cornu, F., Hu, W. X., Wang, X. P. and
Galibert, F. (1992) Genomic organization of the human c-kit
gene: evolution of the receptor tyrosine kinase subclass III.
Oncogene 7; 685–691.
2. Bergfeld, W. F. (1992) Hair disorders. In “Dermatology”, 3rd ed.,
ed. by L. S. Moschlla and J. H. Hurley, W. B. Saunders Company,
Philadelphia, pp. 1541–1560.
3. Blechman, J. M., Lev, S., Brizzi, M. F., Leitner, O., Pegoraro, L.,
Givol, D. and Yarden, Y. (1993) Soluble c-kit proteins and anti-
receptor monoclonal antibodies confine the binding site of the
stem cell factor. J. Biol. Chem. 268; 4399–4406.
4. Botchkareva, N. V., Khlgatian, M., Longley, B. J., Botchkarev, V.
A. and Gilchrest, B. A. (2001) SCF/c-kit signaling is required for
cyclic regeneration of the hair pigmentation unit. FASEB. J. 15;
645–658.
5. Cetin, E. D., Savk, E., Uslu, M., Eskin, M. and Karul, A. (2009)
Investigation of the inflammatory mechanisms in alopecia areata.
Am. J. Dermatopathol. 31; 53–60.
6. Deberry, C., Mou, S. and Linnekin, D. (1997) Stat 1 associates
with c-kit and is activated in response to stem cell factor. Bio-
chem. J. 327; 73–80.
7. Edling, C. E. and Hallberg, B. (2007) c-Kit-a hematopoietic cell
essential receptor tyrosine kinase. Int. J. Biochem. Cell Biol. 39;
1995–1998.
8. Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U.
and Stein, H. (1984) Cell cycle analysis of a cell proliferation-
associated human nuclear antigen defined by the monclonal
antibody Ki-67. J. Immunol. 133; 1710–1715.
9. Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freuden-
berg, J., Brockschmidt, F. F., Flaquer, A., Freudenberg-Hua, Y.,
Jamra, R. A., Metzen, C., Heyn, U., Schweiger, N., Betz, R. C.,
Blaumeiser, B., Hampe, J., Schreiber, S., Schulze, T. G., Hennies,
H. C., Schumacher, J., Propping, P., Ruzicka, T., Cichon, S.,
Wienker, T. F., Kruse, R. and Nothen, M. M. (2005) Genetic vari-
ation in the human androgen receptor gene is the major determi-
nant of common early-onset androgenetic alopecia. Am. J. Hum.
Genet. 77; 140–148.
10. Hombach-Klonisch, S., Panigrahi, S., Rashedi, I., Seifert, A.,
Alberti, E., Pocar, P., Kurpisz, M., Schulze-Osthoff, K.,
Mackiewicz, A. and Los, M. (2008) Adult stem cells and their
trans-differentiation potential—perspectives and therapeutic
applications. J. Mol. Med. 86; 1301–1314.
11. Inaba, M. and Inaba, Y. (1996) Androgenetic Alopecia: Modern
Concepts of Pathogenesis and Treatment, Springer-Verlag,
Tokyo.
12. Kato, K., Hasui, K., Wang, J., Kawano, Y., Aikou, T. and Murata,
F. (2008) Homeostatic mass control in gastric non-neoplastic epi-
thelia under infection of Helicobacter pylori: an immunohisto-
chemical analysis of cell growth, stem cells and programmed cell
death. Acta Histochem. Cytochem. 41; 23–38.
13. Kawamoto, A. and Asahara, T. (2007) Role of progenitor endo-
thelial cells in cardiovascular disease and upcoming therapies.
Catheter Cardiovasc. Interv. 70; 477–484.
14. Kos, L. and Conlon, J. (2009) An update on alopecia areata. Curr.
Opin. Pediatr. 21; 475–480.
15. Lavker, R. M., Bertolino, A. P., Freedberg, I. M. and Sun, T.-T.
(1999) Biology of hair follicle. In “Fitzpatrick’s Dermatology in
General Medicine”, 5th ed., ed. by I. M. Freedberg, Z. A. Eisen,
K. Wolff, F. K. Austen, A. L. Goldsmith, I. S. Katz and B. T.
Fitzpatrick, McGraw-Hill, New York, pp. 230–238.
16. Lazennec, G. and Jorgensen, C. (2008) Concise review: adult
multipotent stromal cells and cancer: risk or benefit? Stem Cells
26; 1387–1394.
17. Lev, S., Yarden, Y. and Givol, D. (1992) A recombinant
ectodomain of the receptor for the stem cell factor (SCF) retains
ligand-induced receptor dimerization and antagonizes SCF-
stimulated cellular responses. J. Biol. Chem. 267; 10866–10873.
18. Miyauchi, S., Hashimoto, K. and Miki, Y. (1990) The innermost
cell layer of the outer root sheath is positive with Ki-67. J. Invest.Involvement of c-kit in Alopecia 17
Dermatol. 95; 393–396.
19. More, K. A. and Lemischka, I. R. (2006) Stem cells and their
niches. Science 311; 1880–1885.
20. Murphy, G. F. (1997) Histology of the skin. In “Lever’s Histo-
pathology of the Skin” 8th ed., ed. by D. Elder, R. Elenitsas, C.
Jaworsky and B. Johnson Jr., Lippincott-Raven, Philadelphia,
pp. 5–50.
21. Nishikawa, S., Kusakabe, M., Yoshinaga, K., Ogawa, M.,
Hayashi, S., Kunisada, T., Era, T., Sakakura, T. and Nishikawa, S.
(1991) In utero manipulation of coat color formation by a mono-
clonal anti-c-kit antibody: two distinct waves of c-kit dependency
during melanocyte development. EMBO. J. 10; 2111–2118.
22. Ohyama, M. (2007) Hair follicle bulge: a fascinating reservoir of
epithelial stem cells. J. Dermatol. Sci. 46; 81–89.
23. Olsen, E. A. (1999) Hair disorders. In “Fitzpatrick’s Dermatology
in General Medicine”, 5th ed., ed. by I. M. Freedberg, Z. A.
Eisen, K. Wolff, F. K. Austen, A. L. Goldsmith, I. S. Katz and
B. T. Fitzpatrick, McGraw-Hill, New York, pp. 751–751.
24. Paus, R. and Cotsarelis, G. (1999) The biology of hair follicles.
New Engl. J. Med. 341; 491–497.
25. Peters, E. M., Maurer, M., Botchkarev, V. A., deMasey Jensen,
K., Welker, P., Scott, Z. A. and Paus, R. (2003) Kit is expressed
by epithelial cells in vivo. J. Invest. Dermatol. 121; 976–984.
26. Peters, E. M., Tobin, D. J., Botchkareva, N., Maurer, M. and
Paus, R. (2002) Migration of melanoblasts into the developing
murine hair follicle is accompanied by transient c-kit expression.
J. Histochem. Cytochem. 50; 751–766.
27. Randall, V. A. (2008) Androgens and hair growth. Dermatol.
Ther. 21; 314–328.
28. Randall, V. A., Jenner, T. J., Hibberts, N. A., De Oliveira, I. O.
and Vafaee, T. (2008) Stem cell factor/c-kit signaling in normal
and androgenetic alopecia hair follicles. J. Endocrinol. 197; 11–
23.
29. Schneider, M. R., Schmidt-Ullrich, R. and Paus, R. (2009) The
hair follicle as a dynamic miniorgan. Curr. Biol. 19; R132–R142.
30. Scholzen, T. and Gerdes, J. (2000) The Ki-67 protein: from the
known and the unknown. J. Cell. Physiol. 182; 311–322.
31. Tang, B., Mano, H., Yi, T. and Ihle, J. N. (1994) The kinase asso-
ciates with c-kit and its tyrosine phosphorylated and activated fol-
lowing stem cell factor binding. Mol. Cell. Biol. 14; 8432–8437.
32. Tobin, D. J. and Paus, R. (2001) Graying: gerontobiology of the
hair follicle pigmentary unit. Exp. Gerontol. 36; 29–54.
33. van Baar, H. M., Perret, C. M., van Vlijmen, I. M., van de
Kerkhof, P. C., Happle, R. and Schalkwijk, J. (1992) Abnormal
expression of Ki-67 antigen in hair follicle of alopecia areata.
This is an open access article distributed under the Creative Commons Attribu-
tion License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Acta Derm. Venereol. 72; 161–164.